Cannabics Pharmaceuticals appoints Dr. Gil Feiler as Independent Board Member

CNBX Pharmaceuticals Inc.

Dr. Gil Feiler appointed as Independent Board Member effective July 15, 2021.
Feiler brings 25+ years executive experience; director of Bank of Georgia, former board member of First International Bank of Israel.
Feiler also heads company's Advisory Board; holds BA, MA, and PhD from Tel Aviv University.
Appointment made by Board resolution; no other changes to board or management disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Gil Feiler

Independent Board Member

CNBX · CNBX Pharmaceuticals Inc.

Effective: 2021-07-15
Filed: July 19, 2021, 7:59 PM ET

On July 15th, 2021, the Board of Directors appointed Dr. Gil Feiler as an Independent Board Member

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Gil Feiler was appointed as Independent Board Member at CNBX Pharmaceuticals Inc..

Action: appointed
Role: Independent Board Member

Exact text from the filing

On July 15th, 2021, the Board of Directors appointed Dr. Gil Feiler as an Independent Board Member

View on SEC.gov

CNBX Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001683168-21-003010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.